image of Ted Ruel
  • Telehealth Visits
bch logo

Ted Ruel, MD

Pediatric Infectious DiseasesChief, Pediatric Infectious Diseases and Global Health
image of Ted Ruel
image of Ted Ruel
bch logo

Ted Ruel, MD

Pediatric Infectious DiseasesChief, Pediatric Infectious Diseases and Global Health
  • Telehealth Visits

On this page

About me

Dr. Ted Ruel is a specialist in pediatric infectious diseases who cares for children living with HIV, from infancy through young adulthood. He provides consultation to pregnant people with HIV, around decisions around delivery and breastfeeding. He provides infectious disease consultations for children admitted to the hospital. He serves as chief of the UCSF Division of Pediatric Infectious Diseases and Global Health.

In his research, Ruel aims to improve the care of all children living with HIV and to prevent new infections in infants. He co-founded Global Strategies, a nonprofit that aims to advance HIV care and maternal-child health around the world.

Ruel earned his medical degree at the Yale School of Medicine. He completed a residency in pediatrics and a fellowship in pediatric infectious diseases at UCSF.

Education

Board Certification

  • Pediatric Infectious Disease, American Board of Pediatrics

Fellowship

  • Pediatric Infectious Disease, UCSF Medical Center - OMAG

Residency

  • Pediatrics, UCSF Medical Center - OMAG

Internship

  • Pediatrics, UCSF Medical Center - OMAG

School

  • MD, Yale University School of Medicine

Academic Title

  • Clinical Professor

Care Keywords

  • Services
    • Pediatric Infectious Diseases

Provider Research Listing

Browse clinical trials and publications by this provider

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.